ENTA · Enanta Pharmaceuticals Inc

$12.45 -0.16 (-1.27%) At close · Jul 29

Market Cap

$362.03M

29.08M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$803,300	—	$128,550	$1,223,975	$591,665	$22,058	$2,769,548
Scott T. Rottinghaus	Chief Medical Officer	$560,300	—	$53,563	$425,943	$281,348	$22,058	$1,343,212
Yat Sun Or	Chief Scientific Officer	$553,150	—	$53,563	$425,943	$239,374	$21,761	$1,293,790

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$779,875	—	$166,367	$1,297,481	$429,455	$22,098	$2,695,276
Matthew P. Kowalsky	Chief Legal Officer and Corporate Secretary	$195,342	—	$74,276	$1,090,560	$111,780	$1,302	$1,473,260
Scott T. Rottinghaus	Chief Medical Officer	$544,000	—	$58,272	$422,664	$210,040	$22,098	$1,257,074
Yat Sun Or	Chief Scientific Officer	$537,050	—	$59,933	$422,664	$181,166	$21,892	$1,222,705
Paul Mellett	CFO	$486,325	—	$56,919	$407,920	$163,277	$22,098	$1,136,539

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$755,375	—	$3,520,440	$3,084,399	$475,886	$20,598	$7,856,698
Nathaniel S. Gardiner	Chief Legal Officer and Corporate Secretary	$475,275	—	$1,146,600	$1,035,806	$176,802	$20,598	$2,855,081
Brendan Luu	Chief Business Officer	$436,075	—	$1,034,100	$920,716	$166,183	$20,598	$2,577,672
Yat Sun Or	Chief Scientific Officer	$501,250	—	$764,324	$985,114	$199,695	$19,218	$2,469,600
Paul Mellett	CFO	$453,975	—	$739,664	$985,114	$177,537	$19,424	$2,375,714
Scott T. Rottinghaus	Chief Medical Officer	$530,250	—	$577,080	$345,269	$190,678	$11,448	$1,654,724
Matthew P. Kowalsky	Chief Legal Officer and Corporate Secretary	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$725,050	—	$2,305,881	$3,739,269	$483,032	$19,424	$7,272,656
Scott T. Rottinghaus	Chief Medical Officer	$77,557	$62,500	$1,597,316	$2,628,960	$29,295	$337	$4,395,965
Nathaniel S. Gardiner	Chief Legal Officer and Corporate Secretary	$458,050	—	$739,664	$985,114	$180,475	$19,424	$2,382,727
Brendan Luu	Chief Business Officer	$411,300	—	$739,664	$985,114	$158,066	$19,424	$2,313,568
Yat Sun Or	Chief Scientific Officer	$486,525	—	$609,830	$652,535	$224,010	$19,211	$1,992,111
Paul Mellett	CFO	$440,381	—	$582,640	$652,535	$192,803	$19,211	$1,887,570
Matthew P. Kowalsky	Chief Legal Officer and Corporate Secretary	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$693,188	—	$1,778,616	$2,283,872	$518,822	$19,211	$5,293,709
Brendan Luu	Chief Business Officer	$254,795	$75,000	$296,203	$1,757,805	$119,813	$1,350	$2,504,966
Tara L. Kieffer	Chief Product Strategy Officer	$305,137	—	$256,227	$1,350,304	$128,250	$2,438	$2,042,356
Yat Sun Or	Chief Scientific Officer	$486,525	—	$609,830	$652,535	$224,010	$19,211	$1,992,111
Nathaniel S. Gardiner	Chief Legal Officer and Corporate Secretary	$444,675	—	$582,640	$652,535	$198,702	$19,211	$1,897,763
Corporate Secretary	—	$444,675	—	$582,640	$652,535	$198,702	$19,211	$1,897,763
Paul Mellett	CFO	$440,381	—	$582,640	$652,535	$192,803	$19,211	$1,887,570
Scott T. Rottinghaus	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$667,063	—	$497,039	$3,598,848	$415,716	$19,171	$5,197,837
Yat Sun Or	Chief Scientific Officer	$472,075	—	$187,821	$981,504	$184,230	$19,171	$1,844,801
Nathalie Adda	Senior Vice President and Chief Medical Officer	$451,550	—	$187,821	$981,504	$173,372	$19,171	$1,813,418
General Counsel	—	$431,025	—	$187,821	$981,504	$169,470	$19,171	$1,788,991
Nathaniel S. Gardiner	General Counsel	$431,025	—	$187,821	$981,504	$169,470	$19,171	$1,788,991
Paul Mellett	CFO	$425,894	—	$187,821	$981,504	$167,453	$19,171	$1,781,843
Tara L. Kieffer	Chief Product Strategy Officer	—	—	—	—	—	—	—
Brendan Luu	Chief Business Officer	—	—	—	—	—	—	—
Scott T. Rottinghaus	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$641,825	—	$457,603	$3,027,598	$337,326	$19,151	$4,483,503
Yat Sun Or	Chief Scientific Officer	$453,900	—	$104,324	$890,470	$162,969	$19,151	$1,630,814
Paul Mellett	CFO	$411,775	—	$104,324	$845,947	$150,366	$19,151	$1,531,563
Nathalie Adda	Senior Vice President and Chief Medical Officer	$421,425	—	$275,275	$630,855	$148,216	$18,851	$1,494,622
Nathaniel S. Gardiner	General Counsel	$398,850	—	$232,925	$577,165	$142,396	$18,851	$1,370,187
Brendan Luu	Chief Business Officer	—	—	—	—	—	—	—
Tara L. Kieffer	Chief Product Strategy Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$611,178	—	$838,530	$2,684,490	$311,150	$18,851	$4,464,199
Yat Sun Or	Chief Scientific Officer	$400,975	—	$574,369	$599,585	$169,955	$18,551	$1,763,435
Nathalie Adda	Senior Vice President and Chief Medical Officer	$400,313	—	$574,369	$599,585	$165,633	$18,551	$1,758,451
Paul Mellett	CFO	$370,728	—	$557,078	$513,930	$147,566	$18,551	$1,607,853
Nathaniel S. Gardiner	General Counsel	$368,100	—	$545,550	$428,275	$149,040	$18,551	$1,509,516

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Luly	CEO	$581,203	—	$1,279,980	$2,055,720	$345,648	$18,551	$4,281,102
Yat Sun Or	Chief Scientific Officer	$400,975	—	$574,369	$599,585	$169,955	$18,551	$1,763,435
Nathalie Adda	Senior Vice President and Chief Medical Officer	$400,313	—	$574,369	$599,585	$165,633	$18,551	$1,758,451
Paul Mellett	CFO	$370,728	—	$557,078	$513,930	$147,566	$18,551	$1,607,853
Nathaniel S. Gardiner	General Counsel	$368,100	—	$545,550	$428,275	$149,040	$18,551	$1,509,516

Key facts CIK 1177648 CUSIP 29251M106 13F (30d) 40 filings 19 filers Visit website Investor relations